| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.09 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.09 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |